Blog
RSS FeedPosted by Michael Wonder on 16 Nov 2017
British Columbia and Prince Edward Island become the first provinces to add Erelzi (etanercept) to public drug plans for the treatment of multiple inflammatory diseases
16 November 2017 - Erelzi also becomes the first biosimilar indicated for polyarticular juvenile idiopathic arthritis under these provincial public drug ...
Posted by Michael Wonder on 15 Nov 2017
Revised procedure for the CADTH Common Drug Review resubmissions
13 November 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission requirements ...
Posted by Michael Wonder on 31 Oct 2017
Drug firms warn Ottawa against ‘crippling’ price cuts
31 October 2017 - Canada's brand-name pharmaceutical companies are pushing back against a plan to overhaul Canada's drug-pricing regulator, saying ...
Posted by Michael Wonder on 30 Oct 2017
Bernie Sanders lauds Canadian health care system in Toronto speech
30 October 2017 - Canada's health care system is a remarkable political accomplishment that bucks a growing global trend toward ...
Posted by Michael Wonder on 23 Oct 2017
The serious flaw in Canada's health care system: prescription drugs aren't free
20 October 2017 - It’s often held up as an example to the world, but the Canadian system doesn’t cover essential ...
Posted by Michael Wonder on 11 Oct 2017
CDR Update — Issue 129
11 October 2017 - In August 2017, CADTH invited stakeholder comments and feedback on a proposal to revise the resubmission ...
Posted by Michael Wonder on 11 Oct 2017
Study finds significant overlap in the drugs covered by Canadian public drug plans
11 October 2017 - The Patented Medicine Prices Review Board, through the National Prescription Drug Utilisation Information System research initiative, ...
Posted by Michael Wonder on 04 Oct 2017
New members appointed to CADTH expert committees
2 October 2017 - Dr. Brian O’Rourke, CADTH President and Chief Executive Officer, is pleased to announce the appointment of four ...
Posted by Michael Wonder on 02 Oct 2017
Revised procedure for advance notification of pending CDR submissions and resubmissions
28 September 2017 - In September 2016, CADTH updated the advance notification procedure for the Common Drug Review. ...
Posted by Michael Wonder on 30 Sep 2017
Blacked-out information reveals secret world of drug prices
30 September 2017 - This week, the Patented Medicine Prices Review Board ruled the Canadian price of the drug Soliris is ...
Posted by Michael Wonder on 28 Sep 2017
Canadian regulator orders price cut of expensive U.S. drug Soliris
27 September 2017 - The maker of the one of the world's most expensive drugs has been ordered to slash ...
Posted by Michael Wonder on 12 Sep 2017
Australia proves national drug plan is possible for Canada
11 September 2017 - A Canadian doctor working in Australia has witnessed how its national drug plan, despite its flaws, is ...
Posted by Michael Wonder on 30 Aug 2017
More Canadians have access to Humira (adalimumab) for the treatment of ulcerative colitis
29 August 2017 - Humira (adalimumab) now reimbursed in British Columbia, Ontario, New Brunswick, Newfoundland and Labrador, Saskatchewan and Yukon. ...
Posted by Michael Wonder on 15 Aug 2017
Posting of key milestones for CDR projects
14 August 2017 - Key milestones for CDR submissions, resubmissions, and requests for advice will now be posted within the ...
Posted by Michael Wonder on 07 Aug 2017
Sask. woman calls on government to cover cystic fibrosis drug
4 August 2017 - A Beauval, Sask. woman wants the Canadian government to cover an expensive drug for her cystic ...